Background
Tuberculosis (TB) remains an important cause of death among patients infected with HIV. Genetic variation influences differential development of TB particularly in Immunosupressed patients. Natural Killer cells play an important role in the innate immune system by providing the first line of defence against viral infections and tumors. Their activity is partially controlled by distinct inhibitory and activating killer Ig like receptors (KIR) that recognize specific ligands on potential target cells. Objective of this study is to determine the association between KIR and HIV co-infection.
Methods
This nested case control study comprised of 68 HIV+ individuals (34 treatment naive HIV-1 slow progressors and 34 on ART patients with TB co-infection). Genomic DNA was extracted from peripheral blood samples by salting out procedure and KIR genotyping was performed for 15 KIR genes (Activating and Inhibitory) by Multiplex PCR sequence specific primer method.
Anzeige
Results
All 15 KIR genes were observed in this study cohort. We could observe more number (>4 aKIR) of activating KIR genes in HIV+ TB– individuals (88%) when compared with HIV+ TB+ patients (74%). Homozygosity for KIR2DL3 was more frequent in HIV+ TB+ patients (64%) than HIV+ TB– individuals (32%) which may confer susceptibility to co-infection.
Conclusion
NK cell receptor KIRs limits HIV disease progression. In the present study, HIV positive individuals who were homozygous for inhibitory KIR2DL3 are at higher risk of acquiring TB co-infection and disease progression with decreased CD4 cells.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.